Speech profile in patients with Huntington's Disease: cognitive, clinical, and sociodemographic correlations.
Nathália Vescia Bauer, Maria Eduarda Soares Machado, Maiara Laís Mallmann Kieling Peres and 2 others
PMID 40834216WHAT IT FOUND
Every patient with Huntington's disease in this small study had impaired speech.
Compared with matched controls, they had worse articulation, phonation and respiration, and speech problems related to motor severity. Use this for assessment awareness, not diagnostic certainty.
Key findings
01All HD case subjects showed impaired prosodic modulation and imprecise articulation; six had speech and breathing discoordination and slow speech rates.
02HD cases had shorter maximum phonation time than controls (5.45 vs 17.22) and higher local jitter (0.87 vs 0.39).
03The study reported Spearman correlations between speech measures and UHDRS motor function: syllable number (ρ = -0.800), speech rate (ρ = -0.857) and maximum phonation time (ρ = -0.893).
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only seven HD case subjects were studied, so the differences and correlations may be unstable and cannot be generalised. The sample was a convenience sample from one specialised centre, so it may not represent people with Huntington's disease in other settings. The text states the number of case subjects but not the exact number of controls analysed. The study was cross-sectional, so it cannot show how speech changes over time or whether these speech patterns predict function. Recordings were made in a silent environment without soundproofing, and not all acoustic variables have established cutoffs for the Brazilian population. No treatment was tested, so the paper does not show which therapy approach works.
Declared interests
Financial support came from Hospital de Clínicas de Porto Alegre - FIPE (GPPG HCPA 2018-0648). No other conflicts-of-interest statement is provided in the supplied text.
The easy way to misread this
Do not treat these speech patterns as a validated biomarker or a treatment target. Only seven patients with Huntington's disease were studied, the design was cross-sectional, and the authors state that the sample limits generalisation.